CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it will provide an overview of its Toll-like Receptor-targeted drug discovery and development programs and a general corporate update at the Rodman & Renshaw 6th Annual Global Healthcare Conference on Monday, May 17, at 12:20 p.m. BST (7:20 a.m. EDT) being held at the Grosvenor House Hotel in London, UK.
